GENITOURINARY DRUGS INDUSTRY MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-102274 | Pharmaceuticals
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Genitourinary Drugs Industry Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET
7.1 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA GENITOURINARY DRUGS INDUSTRY MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Leucomax
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Rhone Poulenc Rorer Inc
16.3 Anturol
16.4 Immunex Corp
16.5 Agouron Pharmaceuticals Inc
16.6 Botox
16.7 Pharmacia & John Inc
16.8 Eli Lilly
16.9 Hoffman-La Roche Inc
16.10 Betanis
16.11 Bristol-Myers Squibb Co
16.12 Abbott Laboratories
16.13 GlaxoSmithKline
16.14 Glaxo Wellcome Plc
16.15 Quadra Logic Technologies Inc
16.16 Pfizer
16.17 Genentech Inc
16.18 Isis Pharmaceuticals
16.19 Astellas
16.20 Bayer AG
16.21 Connaught Laboratories Inc
16.22 Merck & Co
16.23 Merck KGaA
16.24 Chiron Inc
16.25 Schering Plough Corp
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Sex Hormones
Urologicals
Genitourinary Anti-Infectives
Gynaecologicals
Market by Application :
Genitourinary Cancer
Bladder Cancer
Cervical Cancer
Kidney/Renal Cancer
Ovarian Cancer
Prostate Cancer
Companies
Leucomax
Rhone Poulenc Rorer Inc
Anturol
Immunex Corp
Agouron Pharmaceuticals Inc
Botox
Pharmacia & John Inc
Eli Lilly
Hoffman-La Roche Inc
Betanis
Bristol-Myers Squibb Co
Abbott Laboratories
GlaxoSmithKline
Glaxo Wellcome Plc
Quadra Logic Technologies Inc
Pfizer
Genentech Inc
Isis Pharmaceuticals
Astellas
Bayer AG
Connaught Laboratories Inc
Merck & Co
Merck KGaA
Chiron Inc
Schering Plough Corp
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.